Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim

Last Updated: June 9, 2023

Details for New Drug Application (NDA): 005939

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 005939 describes BAL, which is a drug marketed by Akorn, B Braun, Avion Pharms, Solvay, Apotex Inc, Hikma, Mylan, Strides Pharma, Janssen Biotech, and Barr, and is included in twelve NDAs. It is available from one supplier. There are six patents protecting this drug. Additional details are available on the BAL profile page.

The generic ingredient in BAL is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 005939
Formulation / Manufacturing:see details
Pharmacology for NDA: 005939
Mechanism of ActionMetal Chelating Activity
Medical Subject Heading (MeSH) Categories for 005939
Suppliers and Packaging for NDA: 005939
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BAL dimercaprol INJECTABLE;INJECTION 005939 NDA Akorn 17478-526 17478-526-03 10 AMPULE in 1 CARTON (17478-526-03) / 3 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength10%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.